This study is to evaluate the safety and effectiveness of the study vaccine that may protect against pneumococcal pneumonia. The study will last approximately 6 months, with 2 visits to our office and 1 telephone call. Compensation for time and travel may be available up to $100 for those who qualify.
This research study is to evaluate the safety and effectiveness of a vaccine given to women between the ages of 18 – 45 to increase antibodies to RSV infection. Compensation is available up to $925 for time and travel for those who qualify.
We are currently enrolling generally healthy individuals over the age of 18 years old for a Pnuemococcal vaccine research study. The study will last approximately 6 months to find a vaccine to better protect agains pneumococcal disease.
Researching an investigational drug administered orally once daily in patients with knee osteoarthritis. The drug is aimed at reducing cartilaginous degradation and hopefully improve pain and function in the arthritic knee.
Rochester Clinical Research is currently enrolling for a 60 week long research study to evaluate the efficiency of a daily oral migraine investigational medication. 16 visits to Rochester Clinical Research will be a requirement throughout the study.